Related Experiment Video
Updated: Jan 21, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Transforming growth factor β signaling pathway: A promising therapeutic target for cancer
Yuhong Chen1,2,3,4, Cuixia Di1,2,3,4, Xuetian Zhang1,2,3,4
1Department of Radiation Medicine, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Abstract:
Transforming growth factor β (TGF-β) is part of the transforming growth factor β superfamily which is involved in many physiological processes and closely related to the carcinogenesis. Here, we discuss the TGF-β structure, function, and its canonical Smads signaling pathway. Importantly, TGF-β has been proved that it plays both tumor suppressor as well as an activator role in tumor progression. In an early stage, TGF-β inhibits cell proliferation and is involved in cell apoptosis. In an advanced tumor, TGF-β signaling pathway induces tumor invasion and metastasis through promoting angiogenesis, epithelial-mesenchymal transition, and immune escape. Furthermore, we are centered on updated research results into the inhibitors as drugs which have been studied in preclinical or clinical trials in tumor carcinogenesis to prevent the TGF-β synthesis and block its signaling pathways such as antibodies, antisense molecules, and small-molecule tyrosine kinase inhibitors. Thus, it is highlighting the crucial role of TGF-β in tumor therapy and may provide opportunities for the new antitumor strategies in patients with cancer.
Insights
Transforming growth factor β (TGF-β) has a dual role in cancer, initially suppressing tumors but later promoting invasion and metastasis. Inhibitors targeting TGF-β signaling offer new antitumor strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor β (TGF-β) is a key regulator of cellular processes.
- TGF-β signaling is implicated in various physiological functions and carcinogenesis.
- The canonical Smads signaling pathway mediates TGF-β's cellular effects.
Purpose of the Study:
- To review the structure, function, and signaling pathways of TGF-β.
- To elucidate the dual role of TGF-β in tumor suppression and progression.
- To discuss emerging TGF-β inhibitors for cancer therapy.
Main Methods:
- Literature review of TGF-β structure and function.
- Analysis of TGF-β's role in early and advanced tumor stages.
- Overview of preclinical and clinical studies on TGF-β inhibitors.
Main Results:
- TGF-β acts as a tumor suppressor in early stages by inhibiting proliferation and promoting apoptosis.
- In advanced cancers, TGF-β signaling drives invasion, metastasis, angiogenesis, epithelial-mesenchymal transition, and immune escape.
- Various inhibitors, including antibodies, antisense molecules, and small-molecule tyrosine kinase inhibitors, are under investigation.
Conclusions:
- TGF-β plays a critical, context-dependent role in tumor development.
- Targeting TGF-β synthesis and signaling pathways presents promising avenues for novel cancer therapies.
- Further research into TGF-β inhibitors could lead to improved antitumor strategies.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Insulin: The Receptor and Signaling Pathways
IP3/DAG Signaling Pathway
Nitric Oxide Signaling Pathway

